TP53 and non-small cell lung carcinoma: This observation is in line with findings reported by Liu and colleagues in TP53-defective bladder cancer [28] – whereas others have demonstrated p53-dependent mechanisms in non-small cell lung cancer via direct regulation of p21 and PUMA [29].